Nouveau Life Pharmaceuticals, Inc. (NOUV)

USD 0.0

(-50.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2007 2006
Revenue - - - - - -
Cost of Revenue - - - - - -
Gross Profit - - - - - -
Operating Expenses - - - - 357.24 Thousand 267.31 Thousand
Selling, General and Administrative Expenses - - - - 160.5 Thousand 176.83 Thousand
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses - - - - 357.24 Thousand 267.31 Thousand
Operating Income - - - - 357.24 Thousand 267.31 Thousand
Interest Expense - - - - - -
Income Tax Expense - - - - - -10.5 Thousand
Earnings before Tax - - - - 347.75 Thousand 266.24 Thousand
Net Income - - - - -357.24 Thousand -256.81 Thousand
Earnings Per Share Basic - - - - -0.01 -0.01
Earnings Per Share Diluted - - - - -0.01 -0.01
Weighted Average Shares Outstanding - - - - 28.31 Million 25.93 Million
Weighted Average Shares Outstanding (Diluted) - - - - 28.31 Million 25.93 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA - - - - -213.91 Thousand -213.24 Thousand
Earnings Before Tax Margin - - - - - -

Income Statement Charts